Artificial Intelligence Used to Combat Illegal E-Cigarette Sales Online

Aug.02.2024
Artificial Intelligence Used to Combat Illegal E-Cigarette Sales Online
UK non-profit develops AI technology AIVA to combat illegal e-cigarette sales online, identifying hundreds of unauthorized products.

According to a report from The Grocer on July 31st, artificial intelligence technology is being used to search and identify illegal e-cigarette products and unauthorized online retailers on the internet.


The technology, known as AIVA (Artificial Intelligence Vape Assessment), was developed by a British non-profit industry association called "Our Vape Advocacy," which is currently carrying out a mission to eliminate all illegal e-cigarettes.


James Van Aalst, the developer of AIVA and the General Manager of "We Advocate for e-Cigarettes," stated:


AIVA is able to review each website and advertisement in a way that closely resembles human scrutiny, as it understands the marketing tactics of e-cigarette retailers.


He added:


It can cross-reference product images with products being sold and identify advertisements that do not comply with approved products by the pharmaceutical regulatory agency. It can also identify products that are often improperly marketed, products that look like cartoons, or products that resemble food items such as ice cream, beverages, or candy.


AIVA is currently in the preliminary testing phase, but has already identified approximately 500 illegal products being sold by around 100 underground sellers.


This AI technology "searches like a human, using Google and other search engines," and it will report illegal products and their reasons for non-compliance.


The information collected by AIVA will be manually reviewed to ensure there are no errors.


By simply clicking, this information will be sent to the relevant agencies responsible for taking action on this.


The "We advocate for e-cigarette" organization is also warning payment processing companies that support underground seller websites, such as Worldpay and Viva Wallet, have been alerted to about 50 websites selling illegal products.


AIVA is currently a free tool that assists the Trading Standards Agency by directly taking action against these violations, but the agency is urging transaction monitoring teams of card terminal providers to collaborate with "We advocate e-cigarette" to avoid penalties.


The industry association stated that AIVA is "an important milestone in our commitment to protecting public health and ensuring the legal sale of e-cigarette products.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Dutch Health Minister Hermans is drafting legislation that would also ban possession of larger quantities of vapes, allowing the Netherlands Food and Consumer Product Safety Authority to intervene earlier and seize stock before proving that trade has taken place.
Apr.13 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12